Showing results (61-70 of 221) with videos related to

Sort By:
Pageof 23
Oncogene|July 26, 2003
Tyrosine kinase oncoprotein, RET/PTC3, induces the secretion of myeloid growth and chemotactic factorsJohn P Russell, Shogo Shinohara, Rosa M Melillo, et al.
International Journal of Molecular Sciences|November 13, 2020
BDNF rs6265 Polymorphism and Its Methylation in Patients with Stroke Undergoing RehabilitationMassimo Santoro, Mariacristina Siotto, Marco Germanotta, et al.
Frontiers in Cell and Developmental Biology|March 16, 2019
Nano-Sampling and Reporter Tools to Study Metabolic Regulation in ZebrafishThomas Dickmeis, Yi Feng, Maria Caterina Mione, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|January 3, 2018
Expanded [CCTG]n repetitions are not associated with abnormal methylation at the CNBP locus in myotonic dystrophy type 2 (DM2) patientsMassimo Santoro, Luana Fontana, Francesca Maiorca, et al.
Neurotoxicity Research|October 31, 2014
Evaluation of levodopa and carbidopa antioxidant activity in normal human lymphocytes in vitro: implication for oxidative stress in Parkinson's diseaseMonica Colamartino, Massimo Santoro, Guglielmo Duranti, et al.
The New England Journal of Medicine|September 16, 2005
Prophylactic thyroidectomy in multiple endocrine neoplasia type 2AMichael A Skinner, Jeffrey A Moley, William G Dilley, et al.
Diagnostic Cytopathology|May 15, 2008
Training, credentialing and re-credentialing for the performance of a thyroid FNA: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science ConferenceBritt-Marie E Ljung, Jill Langer, Ernest L Mazzaferri, et al.
Oncogene|June 9, 2004
Disease associated mutations at valine 804 in the RET receptor tyrosine kinase confer resistance to selective kinase inhibitorsFrancesca Carlomagno, Teresa Guida, Suresh Anaganti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2007
Sorafenib inhibits imatinib-resistant KIT and platelet-derived growth factor receptor beta gatekeeper mutantsTeresa Guida, Suresh Anaganti, Livia Provitera, et al.
Cancer Research|June 17, 2006
The receptor-type protein tyrosine phosphatase J antagonizes the biochemical and biological effects of RET-derived oncoproteinsAngela Iervolino, Rodolfo Iuliano, Francesco Trapasso, et al.
Pageof 23